Log In
BCIQ
Print this Print this
 

calcipotriene (Sorilux)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionVitamin D analog
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPsoriasis
Indication DetailsTreat plaque psoriasis; Treat scalp psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$50.1M

$50.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/18/2016

$50.1M

$50.1M

0

Get a free BioCentury trial today